Drugs / Another Available A1PI
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT05466747 Comparator | Jan 2024 → Apr 2027 | alpha 1-antitrypsin deficiency, chronic obstructive pulmonary disease | Takeda | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Another Available A1PI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05466747 ↗ |
| Route | Intravenous | “Another available A1PI administered through an IV injection.” NCT05466747 ↗ |